New Drug Shrinks Tumors in Hard-to-Treat Lung Cancer

A groundbreaking therapy is showing real promise against cancers long considered impossible to treat, shrinking tumors in patients who'd run out of options.

The experimental drug targets a genetic mutation affecting thousands of lung and pancreatic cancer patients each year.